Almirall SA ALM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALM is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- €8.22
- Day Range
- €8.08–8.30
- 52-Week Range
- €7.16–10.08
- Bid/Ask
- — / —
- Market Cap
- €1.73 Bil
- Volume/Avg
- 196,575 / 185,497
Key Statistics
- Price/Earnings (Normalized)
- 178.69
- Price/Sales
- 1.82
- Dividend Yield (Trailing)
- 2.23%
- Dividend Yield (Forward)
- 2.23%
- Total Yield
- 2.24%
Company Profile
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company’s operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,885
- Website
- http://www.almirall.es
Comparables
Valuation
Metric
|
ALM
|
BEACONPHAR
|
RJF
|
---|---|---|---|
Price/Earnings (Normalized) | 178.69 | 71.72 | 1.14 |
Price/Book Value | 1.18 | 7.24 | 0.96 |
Price/Sales | 1.82 | 4.87 | 0.62 |
Price/Cash Flow | 11.55 | — | 6.39 |
Price/Earnings
ALM
BEACONPHAR
RJF
Financial Strength
Metric
|
ALM
|
BEACONPHAR
|
RJF
|
---|---|---|---|
Quick Ratio | 1.52 | 0.39 | 0.76 |
Current Ratio | 2.05 | 1.22 | 1.47 |
Interest Coverage | −2.16 | 1.76 | 15.00 |
Quick Ratio
ALM
BEACONPHAR
RJF
Profitability
Metric
|
ALM
|
BEACONPHAR
|
RJF
|
---|---|---|---|
Return on Assets (Normalized) | 0.05% | 4.32% | 3.73% |
Return on Equity (Normalized) | 0.08% | 10.35% | 6.19% |
Return on Invested Capital (Normalized) | 0.13% | 9.14% | 5.00% |
Return on Assets
ALM
BEACONPHAR
RJF
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ptzztqcdc | Ssmh | $77.5 Bil | |
MKKGY
| Merck KGaA ADR | Sssqktwjl | Hdfkpy | $76.9 Bil | |
HLN
| Haleon PLC ADR | Bcjzptgw | Wsd | $38.4 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yrnztpy | Nxq | $15.9 Bil | |
VTRS
| Viatris Inc | Svlzqvhq | Ktdnm | $14.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ylksqkygj | Hhpww | $12.3 Bil | |
CTLT
| Catalent Inc | Ykxvfznd | Krfff | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Chhxdylh | Kzvfz | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Rrhwrwjxk | Pmndc | $3.9 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wldbxjjg | Mytvm | $3.6 Bil |